Probiotics Alleviate IBS Symptoms

Published Online: Tuesday, November 1, 2005

The etiology of irritable bowel syndrome (IBS) has not been fully defined, and the effects of probiotics on this gastrointestinal (GI) motility disorder remain unclear. Kajsa Kajander, MSc, and colleagues conducted a randomized, double-blind, placebo-controlled trial to investigate the effects of a probiotic mixture containing Lactobacillus rhamnosus GG, L rhamnosus LC705, Bifidobacterium breve Bb99, and Propionibacterium freudenreichii subsp shermanii JS on IBS symptoms.

Patients meeting Rome I or Rome II criteria for IBS (n = 103) were treated with a probiotic capsule or a placebo daily for 6 months. GI symptoms and bowel habits were recorded.

At the end of the study, the median reduction in symptom score (abdominal pain + distension + flatulence + borborygmi) was 42% in the probiotic group, compared with 6% in the placebo group (P = .015). For individual symptoms, borborygmi was milder in the probiotic group (P = .008), but no significant trends were observed for other individual symptoms. These results suggested that this probiotic mixture is effective in alleviating symptoms associated with IBS (Alimentary Pharmacology and Therapeutics, September 2005).

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues